Financial policy issues for HIV pre-exposure prophylaxis: cost and access to insurance

Am J Prev Med. 2013 Jan;44(1 Suppl 2):S125-8. doi: 10.1016/j.amepre.2012.09.039.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Anti-HIV Agents / administration & dosage
  • Anti-HIV Agents / economics*
  • Deoxycytidine / analogs & derivatives*
  • Deoxycytidine / economics
  • Drug Combinations
  • Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
  • HIV Infections / prevention & control*
  • Humans
  • Insurance Coverage
  • Insurance, Health*
  • Organophosphorus Compounds / economics*
  • Primary Prevention / economics*

Substances

  • Anti-HIV Agents
  • Drug Combinations
  • Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
  • Organophosphorus Compounds
  • Deoxycytidine